US Edition
Medtronic’s GSR-DEFINE Study of Symplicity Spyral RDN System Enrolls First United States Patient - Cardiac Interventions Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Medtronic’s GSR-DEFINE Study of Symplicity Spyral RDN System Enrolls First United States Patient - Cardiac Interventions Today
June 11, 2025—Medtronic announced the treatment of the first patient in the United States in the Global SYMPLICITY Registry (GSR) DEFINE. The clinical study is documenting the safety and effectiveness of the company’s Symplicity Spyral renal denervation (RDN) system in a real-world setting. The company stated that the first United States procedure was performed by Stan Thornton, MD, of Thomas Hospital, an affiliate of Infirmary Health in Fairhop…
Medtronic’s GSR-DEFINE Study of Symplicity Spyral RDN System Enrolls First United States Patient - Endovascular Today
June 11, 2025—Medtronic announced the treatment of the first patient in the United States in the Global SYMPLICITY Registry (GSR) DEFINE. The clinical study is documenting the safety and effectiveness of the company’s Symplicity Spyral renal denervation (RDN) system in a real-world setting. The company stated that the first United States procedure was performed by Stan Thornton, MD, of Thomas Hospital, an affiliate of Infirmary Health in Fairhop…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
